Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZX100 for keloid scar recurrence
NCT00892723Phase 2Completed
- Sponsor
- OrthoLogic Corp.
- Start
- May 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of azx-100 in keloid, sponsored by OrthoLogic Corp.. Started May 2009; status: completed.
02
Drugs
azx-100
03
Conditions
keloid
Beyond the preview
Go deeper on NCT00892723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892723.